Hong Kong Pharmaceuticals Stock News

Bank of Chongqing (SEHK:1963) has drawn fresh attention after shareholders approved a final dividend of RMB 0.2797 per share for 2025 at the 23 June 2026 AGM, highlighting the stock’s income profile. See our latest analysis for Bank of Chongqing. The final dividend decision comes as Bank of Chongqing’s HK$7.47 share price has slipped over the last month, with a 30 day share price return of a 13.94% decline, while the 5 year total shareholder return of 130.98% points to a much stronger longer...

Fresh sales update puts Longfor Group Holdings in focus Longfor Group Holdings (SEHK:960) has drawn fresh attention after reporting unaudited preliminary figures for June 2026 and the first half of the year, giving investors new data on contracted sales and revenue mix. In June 2026, the group reported contracted sales of RMB2.88b, covering 299,000 sqm of gross floor area, with RMB1.90b of those sales and 209,000 sqm attributable to shareholders of the company. For the six months to 30 June...

Mixed June Output Highlights Shifts Within CGN New Energy Holdings Portfolio CGN New Energy Holdings (SEHK:1811) has released preliminary operating data for June and the first half of 2026, showing overall power generation declines but contrasting trends across wind, solar, gas, hydro and Korea projects. For June 2026, group power generation was 1,331.5 GWh, down 5.1% year on year. Within this total, PRC wind output fell 17.1%, PRC solar rose 33.5%, PRC gas-fired increased 6.3%, PRC hydro...

Amidst the backdrop of renewed geopolitical tensions in the Middle East and fluctuating energy prices, Asian markets have been navigating a complex economic landscape. In such times, penny stocks—often smaller or newer companies—can offer intriguing opportunities for investors who are willing to explore beyond traditional large-cap investments. While the term "penny stock" might seem outdated, these stocks can still represent valuable prospects when they are backed by strong financials and...

Jiangxi Copper (SEHK:358) has issued new first half 2026 earnings guidance, projecting net profit attributable to shareholders of approximately CN¥7.55 billion to CN¥8.50 billion, supported by cost reductions and higher market prices for core products. See our latest analysis for Jiangxi Copper. Jiangxi Copper’s earnings guidance arrives after a weak share price stretch, with the stock down 9.61% on a 30 day share price return and 28.53% on a year to date share price return. However, the 1...

As geopolitical tensions and energy market volatility continue to influence global markets, Asian equities have shown mixed performance, with technology stocks experiencing notable fluctuations. In this environment, identifying undervalued stocks—those trading below their intrinsic worth—can provide opportunities for investors seeking value in a complex economic landscape.

Amidst renewed geopolitical tensions and energy market volatility, Asian markets have been navigating a complex economic landscape. For investors willing to explore beyond the well-trodden paths of major indices, penny stocks—typically representing smaller or newer companies—continue to offer intriguing opportunities. While the term may seem outdated, these stocks can provide a unique blend of growth potential and value when supported by strong financials, making them an appealing option for...

Great Wall Motor (SEHK:2333) is back in focus after signing a new Global Strategic Cooperation Framework Agreement with Autoliv, alongside fresh June 2026 production and sales updates that give investors more operational context. See our latest analysis for Great Wall Motor. Despite the new cooperation framework with Autoliv and the latest production and sales update, Great Wall Motor’s share price has fallen sharply in recent months. The 30 day share price return is down 15.71% and the year...

Geely Automobile Holdings (SEHK:175) has released unaudited sales figures for June 2026, with monthly and year to date vehicle volumes above the same period last year, giving investors fresh data on the company’s operational momentum. See our latest analysis for Geely Automobile Holdings. At a latest share price of HK$18.64, Geely Automobile Holdings has seen a 2.81% 1 day share price gain and a 1.86% 7 day share price return, but the 30 day share price return is down 3.87% and the 90 day...

Alibaba Health Information Technology Limited previously announced proposed amendments to its bye-laws, seeking shareholder approval to give its Board more flexibility in declaring dividends, align with Hong Kong’s evolving uncertificated and paperless listing rules, and implement various housekeeping changes. A key change would allow the Board to pay dividends or make distributions not only from profits but also from contributed surplus, potentially reshaping how investors think about...

Wharf Real Estate Investment (SEHK:1997) has drawn attention after moving to sell its Singapore Orchard Road properties, Wheelock Place and Scotts Square, a portfolio acquired in 2019 and recently valued at HK$7.7b. See our latest analysis for Wharf Real Estate Investment. The Orchard Road sale plans come after a mixed period for Wharf Real Estate Investment, with a 1-year total shareholder return of 7.49% contrasting with a 3-year total shareholder return that is down 32.48%. The 1-year...

COSCO SHIPPING International (Hong Kong) (SEHK:517) shares were in focus after the company reported the passing of independent non executive director Mr. Kwong Che Keung, Gordon, who also chaired its audit committee. See our latest analysis for COSCO SHIPPING International (Hong Kong). The recent board change comes at a time when COSCO SHIPPING International (Hong Kong) shares trade at HK$5.44, with a 30 day share price return that is down 9.33% and a 90 day share price return that is down...

Kuaishou Technology (SEHK:1024) began repurchasing its shares on July 3, 2026 under a shareholder-mandated program allowing buybacks of up to 432,690,765 shares, or 10% of its issued capital, funded from legally available resources in line with Cayman Islands regulations. The company expects these repurchases, alongside its recent quarterly revenue growth and HK$2.88 billion net profit, to lift net asset value per share and/or earnings per share, underscoring management’s focus on capital...

Many Duality Biotherapeutics, Inc. ( HKG:9606 ) insiders ditched their stock over the past year, which may be of...

China Tobacco International (HK) (SEHK:6055) is back in focus after chairman and non executive director Mr. Shao Yan retired, leaving key board and committee roles temporarily vacant and prompting interim governance arrangements. See our latest analysis for China Tobacco International (HK). China Tobacco International (HK)'s share price has fallen 6.85% over the past month and 42.85% over the past 90 days, yet its 3 year total shareholder return of 91.10% means longer term holders have still...

Innovent Biologics (SEHK:1801) has drawn fresh attention after securing exclusive commercialization rights for Eli Lilly’s breast cancer drug Verzenios in mainland China. This adds a reimbursed oncology product to its existing portfolio. See our latest analysis for Innovent Biologics. The Verzenios agreement lands at a time when Innovent Biologics’ share price has a 30 day share price return of 22.96% and a year to date share price return of 13.83%. Its 3 year total shareholder return of...

Dividend details and key dates for Huishang Bank stock Huishang Bank (SEHK:3698) has approved a final ordinary cash dividend of RMB 2.5 per 10 shares, or HK$2.87488 per 10 shares, for the 2025 financial year. Shareholders approved the payout on 30 June 2026, with the ex-dividend date set for 6 July, the record date on 13 July, and payment scheduled for 21 August 2026. See our latest analysis for Huishang Bank. Huishang Bank's share price is HK$4.54, with a 1 day share price return of 1.11%...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Shougang...

Looking at BeijingWest Industries International Limited's ( HKG:2339 ) insider transactions over the last year, we can...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Board moves on capital and governance draw focus to Shanghai Conant Optical Shanghai Conant Optical (SEHK:2276) has put a proposed reduction of its registered capital and amendments to its Articles of Association on the agenda, bringing corporate structure and governance questions to the foreground for investors. See our latest analysis for Shanghai Conant Optical. For Shanghai Conant Optical, the latest HK$31.78 share price sits against a short-term backdrop of weaker momentum, with the...

Pico Far East Holdings (SEHK:752) has reported its H1 2026 results with context that matters for investors, coming off H2 2025 revenue of HK$3.7 billion, basic EPS of HK$0.178, and net income of HK$223.7 million. The company has seen revenue move from HK$3.4 billion with EPS of HK$0.134 in H2 2024 to HK$3.5 billion and EPS of HK$0.171 in H1 2025, before reaching HK$3.7 billion and EPS of HK$0.179 in H2 2025, against a backdrop of trailing 12 month earnings growth of 14.1%. With net profit...

WuXi Biologics (Cayman) (SEHK:2269) is back in focus after its MFG8 facility in Hebei cleared a seven day U.S. FDA Pre License Inspection, supporting commercial production of a potential autoimmune therapy. See our latest analysis for WuXi Biologics (Cayman). At a share price of HK$37.96, WuXi Biologics (Cayman) has seen a 26.79% 30 day share price return and a 16.66% year to date share price return. Its 1 year total shareholder return of 42.44% contrasts with weaker multi year total...